Publication Name	World Journal of Clinical Cases
Manuscript ID	81204
Country	France

Received	2022-10-29 14:32
Peer-Review Started	2022-10-29 14:33
To Make the First Decision
Return for Revision	2023-01-12 00:54
Revised	2023-01-17 21:34
Second Decision	2023-02-01 03:14
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-02-02 05:21
Articles in Press	2023-02-02 05:21
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-02-09 07:19
Publish the Manuscript Online	2023-02-24 09:09

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Case Report
Article Title	Gemcitabine-induced peripheral vascular disease and prolonged response in a patient with metastatic pancreatic adenocarcinoma: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Moinard-Butot Fabien, Poprawa Elodie, Schohn Anna, Pietro Addeo and Benabdelghani Meher
ORCID	Author(s) ORCID Number Moinard-Butot Fabien http://orcid.org/0000-0002-5630-5220
Funding Agency and Grant Number
Corresponding Author	Moinard-Butot Fabien, MD, Doctor, Department of Medical Oncology, Institut de Cancérologie Strasbourg Europe, 17 Rue Albert Calmette, Strasbourg 67200, France. f.moinard-butot@icans.eu
Key Words	Gemcitabine; Pancreatic cancer; Peripheral vascular disease; Prolonged tumor response; Case report
Core Tip	Gemcitabine is known for vascular side effect. In this case, we report a vascular acrosyndrome that occurred during first-line with Gemcitabine for pancreatic adenocarcinoma. In this case, the patient experienced prolonged tumor response. Immunological phenomena could be responsible for this double effect.
Publish Date	2023-02-24 09:09
Citation	Fabien MB, Elodie P, Anna S, Addeo P, Meher B. Gemcitabine-induced peripheral vascular disease and prolonged response in a patient with metastatic pancreatic adenocarcinoma: A case report. World J Clin Cases 2023; 11(6): 1372-1378
URL	https://www.wjgnet.com/2307-8960/full/v11/i6/1372.htm
DOI	https://dx.doi.org/10.12998/wjcc.v11.i6.1372

Full Article (PDF)	WJCC-11-1372.pdf
Full Article (Word)	WJCC-11-1372.docx
Manuscript File	81204_Auto_Edited-JLW.docx
Answering Reviewers	81204-Answering reviewers.pdf
Audio Core Tip	81204-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	81204-Conflict-of-interest statement.pdf
Copyright License Agreement	81204-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	81204-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	81204-Language certificate.pdf
Peer-review Report	81204-Peer-review(s).pdf
Scientific Misconduct Check	81204-Bing-Ma YJ-2.jpg
Scientific Editor Work List	81204-Scientific editor work list.pdf